Previous 10 | Next 10 |
Suwanee, GA - ( NewMediaWire ) - February 07, 2020 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s e...
SUWANEE, GA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce the completion of our follow on equity offering. The combined offerings have brought over $5 million of investment capital to the company between t...
SUWANEE, GA, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has appointed DIVICOMED SRL as the exclusive distributor for the dermaPACE® System in Bolivia. DIVICOMED SRL is a leading med...
Phoenix, Arizona--(Newsfile Corp. - November 21, 2019) - The Stock Day Podcast welcomed SANUWAVE Health, Inc. (OTCQB: SNWV) ("the Company"), a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices...
SANUWAVE Health, Inc. (SNWV) Q3 2019 Earnings Conference Call November 15, 2019 9:00 AM ET Company Participants Lisa Sundstrom – Chief Financial Officer Kevin Richardson – Chairman and Chief Executive Officer Shri Parikh – President Conference Call Partici...
SUWANEE, Ga., Nov. 15, 2019 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2019 with the SEC on Thursday, November 14, 2019. The Company will also host a conference call today, November 15, 2...
Re-Affirms Guidance of 110 dermaPACE® Placements in 2019 SUWANEE, GA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has signed a distribution partnership agreement with Ametus Group for the commer...
SUWANEE, GA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2019 this week. The Company will also host a conference call on Friday, ...
Company Receives Cash Payments for Territorial Rights SUWANEE, GA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has signed a term sheet for a Brazilian joint venture for the dermaPACE® System ...
SUWANEE, GA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating shockwave systems for the r...
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...